Staging systems for papillary thyroid carcinoma: a review and comparison. - Wikidata - thesis-toulmin - TriplyDB

Staging systems for papillary thyroid carcinoma: a review and comparison.

Staging systems for papillary thyroid carcinoma: a review and comparison.

http://www.wikidata.org/entity/Q36792504

about

Risk Stratification in Differentiated Thyroid Cancer: An Ongoing Process Radioiodine Remnant Ablation: A Critical Review Managing newly diagnosed thyroid cancer The surgical approach to managing differentiated thyroid cancer A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer Prototype nerve-specific near-infrared fluorophores.Current concepts and future directions in differentiated thyroid cancer.Relationship between lymphovascular invasion and clinicopathological features of papillary thyroid carcinoma High expression of GPER1, EGFR and CXCR1 is associated with lymph node metastasis in papillary thyroid carcinoma Clinical Characteristics Related to Central Lymph Node Metastasis in cN0 Papillary Thyroid Carcinoma: A Retrospective Study of 916 Patients.Significance of size of lymph node metastasis on postsurgical stimulated thyroglobulin levels after prophylactic unilateral central neck dissection in papillary thyroid carcinoma Incidental thyroid carcinoma by FDG-PET/CT: a study of clinicopathological characteristics.Analysis of age and disease status as predictors of thyroid cancer-specific mortality using the Surveillance, Epidemiology, and End Results database.The importance of staging systems for the determination of prognosis of well-differentiated thyroid cancer A critical analysis of the American Joint Committee on Cancer (AJCC) staging system for differentiated thyroid carcinoma in young patients on the basis of the Surveillance, Epidemiology, and End Results (SEER) registry Thyroid cancer presentation and treatment in the United States Risk factors for nonsynchronous second primary malignancy and related death in patients with differentiated thyroid carcinoma.Impact of routine unilateral central neck dissection on preablative and postablative stimulated thyroglobulin levels after total thyroidectomy in papillary thyroid carcinoma.Risk Factors for Central Compartment Lymph Node Metastasis in Papillary Thyroid Microcarcinoma: A Meta-Analysis.Significance of metastatic lymph node ratio on stimulated thyroglobulin levels in papillary thyroid carcinoma after prophylactic unilateral central neck dissection.Is there a role for unstimulated thyroglobulin velocity in predicting recurrence in papillary thyroid carcinoma patients with detectable thyroglobulin after radioiodine ablation?Controversies in the management and followup of differentiated thyroid cancer: beyond the guidelines.Postablation stimulated thyroglobulin level is an important predictor of biochemical complete remission after reoperative cervical neck dissection in persistent/recurrent papillary thyroid carcinoma.Evaluating the prognostic factors associated with cancer-specific survival of differentiated thyroid carcinoma presenting with distant metastasis.Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Associat Lean body mass-based levothyroxine replacement in young athyrotic patients with differentiated carcinoma of thyroid.The Trend of Age-Group Effect on Prognosis in Differentiated Thyroid Cancer.Survival from Differentiated Thyroid Cancer: What Has Age Got to Do with It?What is New on Thyroid Cancer Biomarkers Overexpression of HIF-2α, TWIST, and CXCR4 is associated with lymph node metastasis in papillary thyroid carcinoma.The age factor in survival of a population cohort of well-differentiated thyroid cancer.Overexpression of HIF-1α, metallothionein and SLUG is associated with high TNM stage and lymph node metastasis in papillary thyroid carcinoma Risk factors associated with high thyroglobulin level following radioactive iodine ablation, measured 12 months after treatment for papillary thyroid carcinoma.Diagnostic markers and prognostic factors in thyroid cancer.Classification of parathyroid cancer.Ambulatory thyroidectomy: a multistate study of revisits and complications.The role of prophylactic central neck dissection in differentiated thyroid carcinoma: issues and controversies.An Indian Tertiary Care Hospital Scenario of Papillary Carcinoma of Thyroid.Stage II differentiated thyroid cancer: A mixed bag.

P2860

Q26765083-4B31FD9C-E1B1-441B-9449-12C594B8D534 Q26784202-E5513816-4789-4DB5-8CCD-53A4485265E5 Q26825293-B2854E39-D9C6-455C-BE06-D10ADB7E5BEC Q28071863-E1DEB8E8-3E9D-41CA-9E6F-8C44C36B3036 Q28118410-FC997857-0C9C-4C9C-A9AB-6804327CBFE5 Q30367068-8FB308C9-6C32-4A57-9DFA-E75CD249C70A Q30581050-D80D61E9-2AC4-4CCE-B56D-943756D8F9BA Q33677589-B95620A7-5939-4C62-A3DB-036A95AD89D5 Q33808724-DE3DD997-8289-48BC-AFF6-1BC38961D525 Q33898496-E2CA1145-1D99-42A8-8069-B5628DDEF06C Q34151560-24C73A79-8DA1-4705-AC56-A6AA2482A510 Q34260830-4971FC78-B198-4A06-BECF-FA159FDA1A1D Q34544791-C4FB4C96-419D-4BF0-8822-290568249B32 Q34920275-FBBA7EC4-70E4-4229-9D69-0478CDD295E2 Q35233309-01FF0727-1CF9-4FC5-9829-92004A5D5D2C Q35559891-B6DEDBB2-A3F1-40A8-9C38-0C635F7295BF Q35561920-7DC0E1BB-CCE7-4B4B-8132-2C88A35C9E05 Q35569469-4287BA99-AC10-4AD4-BFBF-B81ED41740C2 Q35653514-694090BB-2F6E-4558-9535-84A2CD2C6D62 Q35671130-C7FD0AB3-AA8B-48E2-BBAB-16BE7B9E4792 Q35843018-11A1CCAE-7FA1-457A-85CF-4C003412C123 Q36233648-ED7A406C-4D37-4395-8B54-9449E6500DE4 Q36530119-149C409A-5EF7-460B-993B-561D46DD6E08 Q36578078-7E10DE9E-45BE-4307-9F6A-B19A739561FA Q36689253-F2EC3B00-DFCA-43E4-99CA-2373C9062805 Q36837469-E8F6D990-59E4-462C-9741-9CA976DD74E4 Q36930705-FB05BE05-5874-45FA-83CE-A71DC497E829 Q36980190-972907F6-C957-4B53-AEF0-4924A4C14D24 Q37141849-74EA21FA-1728-4372-9DC1-6813F0DB3FC4 Q37207279-89C12ED7-07D8-49B4-9DCF-AC059F9D7B2E Q37316173-22511AB5-C865-44E5-BEE2-FE1D8A24FDB3 Q37354255-B3BC58D7-7D1C-4000-BC3E-8C35176171A4 Q37452292-D15EF2E4-792B-47DC-BA95-9D6E9EAF7408 Q37585292-80B6C9B5-45FB-43F6-9055-F0C83F1FA956 Q37620399-C89AE8BE-9331-45C3-99FF-47D0F414AD9F Q37995508-877B6C28-4DD4-453C-A5EA-C29DBEC7FCF1 Q38415550-A089890E-6129-4E0C-A8D7-F6970729A5EF Q38603131-1A074CB3-6F89-4D91-ADDC-AED6453765AD Q38648904-2C7816C4-139C-4ABE-AF85-826FB9F2CAC4 Q38656161-A5A2F737-F38C-4584-9FF5-684BCAC05620

P2860

Staging systems for papillary thyroid carcinoma: a review and comparison.

http://www.wikidata.org/entity/Q36792504

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Staging systems for papillary thyroid carcinoma: a review and comparison.

@ast

Staging systems for papillary thyroid carcinoma: a review and comparison.

@en

type

label

Staging systems for papillary thyroid carcinoma: a review and comparison.

@ast

Staging systems for papillary thyroid carcinoma: a review and comparison.

@en

prefLabel

Staging systems for papillary thyroid carcinoma: a review and comparison.

@ast

Staging systems for papillary thyroid carcinoma: a review and comparison.

@en

P1433

Q36792504-88244EFF-FA84-4EA6-8A6F-D247AFFAF9D5

P1476

Q36792504-D605EA9C-D93F-471C-8EEB-B42138E01F46

P2093

Q36792504-2E9A6468-EEBC-4FAF-A2BA-05CC3731CA81

Q36792504-64574FA8-74E7-436C-9934-66D6C359E178

Q36792504-8A47A79B-C87E-4909-B629-EC8C3E56460D

Q36792504-9DE900A4-2550-4676-87B7-43DFB5720EE8

Q36792504-BBC92460-1DB2-462C-B882-4F44FB1C2B4C

P2860

Q36792504-08E4878E-88D1-454B-B8B0-6AE84AB66EE4

Q36792504-0A632DE7-A9A6-4EE4-A801-50EF840CEAD7

Q36792504-2B119FCA-125D-43BF-BA6B-413C8EC94287

Q36792504-32C66C04-76A4-4ED2-970C-1F6CECAD72A9

Q36792504-37ABB657-164F-4D5C-9DF2-8AF9555C5D48

Q36792504-3E3172C1-4DF1-4833-BAA4-413DB0D5F462

Q36792504-6AC2A7F3-A859-45D3-8901-A3C0F19F819A

Q36792504-6E85E408-AD68-4E14-9BFE-132729D9B45C

Q36792504-7B593A8C-85E8-49AE-805A-80B903B70A25

Q36792504-7E83B836-CECC-425A-BA78-914ED8A592ED

P304

Q36792504-519950D1-576B-4403-BFDD-2641488B8686

P31

Q36792504-39FCBEE8-3401-4734-94BA-08ED346C58FA

P356

Q36792504-DD79EAEE-5AC5-4C2E-B5AC-9E1F5DB17BB9

P407

Q36792504-81A36564-D4F4-483E-A016-B957AE4E0FD6

P433

Q36792504-6F3FD18D-2DB8-4A88-AEB8-2216B8DF8D31

P478

Q36792504-123B6644-6BB5-4F09-9072-F89A0BB5430C

P577

Q36792504-AFDD6EAD-66F2-46D5-97B2-6AC66113B646

P5875

Q36792504-7457962A-5221-4ED8-86B3-422FCEF7EA2F

P698

Q36792504-755666C1-215D-42C7-A4B3-7FEF647BAD8C

P932

Q36792504-729D33E8-05C0-481D-A6B8-B3B320883D2F

P356

01.SLA.0000250445.92336.2A

P1433

Annals of Surgery

P1476

Staging systems for papillary thyroid carcinoma: a review and comparison.

@en

P2093

Brian Hung-Hin Lang

http://www.w3.org/2001/XMLSchema#string

Chung-Yau Lo

http://www.w3.org/2001/XMLSchema#string

King-Yin Lam

http://www.w3.org/2001/XMLSchema#string

Koon-Yat Wan

http://www.w3.org/2001/XMLSchema#string

Wai-Fan Chan

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer.

Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989.

Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer.

Cancer staging, prognostic factors, and our surgical challenges.

Classical and follicular variant of papillary thyroid carcinoma: a comparative study on clinicopathologic features and long-term outcome.

Prognostic factors in papillary and follicular thyroid carcinoma: their implications for cancer staging.

Prognostic scoring systems in patients with follicular thyroid cancer: a comparison of different staging systems in predicting the patient outcome.

Intermediate-risk group for differentiated carcinoma of thyroid.

A comparison of different staging systems predictability of patient outcome. Thyroid carcinoma as an example.

Descriptive epidemiology of thyroid cancer in Los Angeles County, 1972-1995.

P304

366-378

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/01.SLA.0000250445.92336.2A

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

245

http://www.w3.org/2001/XMLSchema#string

P577

2007-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6392077

http://www.w3.org/2001/XMLSchema#string

P698

17435543

http://www.w3.org/2001/XMLSchema#string

P932

1877011

http://www.w3.org/2001/XMLSchema#string